Pancreatic Cancer Patients With BRCA Mutations Could Have a New Drug on the Way
source: pixabay.com

Pancreatic Cancer Patients With BRCA Mutations Could Have a New Drug on the Way

According to a story from Worldpharmanews, a PARP inhibitor drug that is commonly used to treat ovarian cancer for patients with BRCA gene mutations could also be effective against pancreatic…

Continue Reading Pancreatic Cancer Patients With BRCA Mutations Could Have a New Drug on the Way
An Experimental Gene Therapy for Cerebral ALD Has Been Granted Breakthrough Therapy Designation by the FDA
Source: Pixabay

An Experimental Gene Therapy for Cerebral ALD Has Been Granted Breakthrough Therapy Designation by the FDA

The U.S. Food and Drug Administration has granted Breakthrough Therapy designation to the experimental drug Lenti-D, which is being produced by the gene therapy company Bluebird bio to treat cerebral…

Continue Reading An Experimental Gene Therapy for Cerebral ALD Has Been Granted Breakthrough Therapy Designation by the FDA
Some People Are Resistant to PARP Inhibitors, and Researchers Have Just Discovered Why
source: pixabay.com

Some People Are Resistant to PARP Inhibitors, and Researchers Have Just Discovered Why

According to a story from Ovarian Cancer News, a recent study has allowed scientists to determine why some people appear to be resistant to poly ADP ribose polymerase (PARP) inhibitors.…

Continue Reading Some People Are Resistant to PARP Inhibitors, and Researchers Have Just Discovered Why
Genetic Screening Can Prevent Parents from Passing on Genes Linked to Some Diseases
Source: Pixabay

Genetic Screening Can Prevent Parents from Passing on Genes Linked to Some Diseases

The Young family from Oregon, U.S. have used genetic screening to test their embryos for a variation of the BRCA gene that significantly increases the risk of breast cancer, reports…

Continue Reading Genetic Screening Can Prevent Parents from Passing on Genes Linked to Some Diseases
$2.6 million has Been Granted to Researchers Working on Reducing the Side-Effects of Checkpoint Inhibitor Immunotherapies For Cancer Patients
Source: Pixabay

$2.6 million has Been Granted to Researchers Working on Reducing the Side-Effects of Checkpoint Inhibitor Immunotherapies For Cancer Patients

The Melanoma Research Alliance (MRA) and The American Cancer Society (ACS) have announced the first recipients of their new research grants, reports PRNewswire. The grants have been set up as…

Continue Reading $2.6 million has Been Granted to Researchers Working on Reducing the Side-Effects of Checkpoint Inhibitor Immunotherapies For Cancer Patients